Conductive Keratoplasty

New Jersey CK (Conductive Keratoplasty) Refractive Surgery

Conductive Keratoplasty New Jersey / New Jersey CK Surgery New Jersey CK Surgery is performed by Dr. Ed Hedaya, a refractive surgery specialist. Dr Hedaya has extensive training and experience in the treatment of presbyopia. This webpage provides information about Conductive Keratoplasty Surgery and how it has improved the vision of many of his patients from Monmouth County, Ocean County and Tinton Falls New Jersey and around the United States. NearVisionSM CK® (Conductive Keratoplasty) has been recently been approved by the FDA. NearVisionSM CK® unlike CK is the first FDA approved procedure to improve vision for people with presbyopia. NearVisionSM CK® uses radiofrequency (RF) energy instead of a laser. The procedure can be conveniently performed in our office using only a topical (eye drop) anesthesia. For additional information, click here.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

By changing the way your cornea (the clear front surface of the eye) directs light to the rest of your eye, NearVisionSM CK® effectively treats the condition known as presbyopia.

NearVisionSM CK® uses the same controlled release of radiofrequency (RF) energy as CK, instead of a laser, to reshape the cornea. NearVisionSM CK® is performed using a small probe, thinner than a strand of human hair, that releases radiofrequency (RF) energy. The probe is applied in a circular pattern on the outer cornea to shrink small areas of corneal tissue. This circular shrinkage pattern creates a constrictive band (like the tightening of a belt), increasing the overall curvature of the cornea. The procedure, which takes less than three minutes, is done in-office with only topical anesthesia (eye drops).

NearVisionSM CK® is performed without the cutting or removal of tissue. It is a safe, minimally invasive procedure for farsightedness. The use of RF energy is one of today’s most advanced surgical techniques. In addition to its use in NearVisionSM CK®, RF technology is being used in prostate cancer therapy, back surgery, even cardiovascular procedures.

For patients who require treatment in both eyes, NearVisionSM CK® is typically performed on both eyes on the same day – one eye immediately after the other. Most patients are comfortable having the NearVisionSM CK® procedure performed on both eyes on the same day because the procedure is minimally invasive, takes less than three minutes and is done in-office with only topical anesthesia.

Most patients will experience mild fluctuation in their vision after surgery, but few notice it. Any fluctuation will usually subside within a few weeks. Patients who are treated for presbyopia, regardless of the procedure, usually require a longer stabilization period than those treated for myopia. You will not have to wear patches or bandages, however many surgeons will recommend temporary clear lenses (similar to contact lenses but without a prescription) to protect the eyes and to reduce any potential discomfort.

NearVisionSM CK® is performed using a probe (Keratoplast™ Tip) that is as thin as a strand of human hair. The probe, introduced into the cornea, applies controlled radiofrequency (RF) energy, stabilizes the NearVisionSM CK® procedure and guarantees the precise depth of treatment.